The association between sLOX-1 and endothelial dysfunction has been investigated in metabolic syndrome and polycystic ovary syndrome, which are known to cause increased insulin resistance and cardiovascular risk. This evidence concerns the gene OLR1 and polycystic ovary syndrome.